These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 22811397

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Wang XL, Zhang YB, Tang JF, Yang YS, Chen RQ, Zhang F, Zhu HL.
    Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.
    Li Y, Luo Y, Hu Y, Zhu DD, Zhang S, Liu ZJ, Gong HB, Zhu HL.
    Bioorg Med Chem; 2012 Jul 15; 20(14):4316-22. PubMed ID: 22710102
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
    Li Y, Zhao CP, Ma HP, Zhao MY, Xue YR, Wang XM, Zhu HL.
    Bioorg Med Chem; 2013 Jun 01; 21(11):3120-6. PubMed ID: 23602519
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Li HQ, Luo Y, Zhu HL.
    Bioorg Med Chem; 2011 Aug 01; 19(15):4454-9. PubMed ID: 21742506
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents.
    Zhang HJ, Zhu DD, Li ZL, Sun J, Zhu HL.
    Bioorg Med Chem; 2011 Aug 01; 19(15):4513-9. PubMed ID: 21741250
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
    Li ZL, Li QS, Zhang HJ, Hu Y, Zhu DD, Zhu HL.
    Bioorg Med Chem; 2011 Aug 01; 19(15):4413-20. PubMed ID: 21752655
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Design of Arylsulfonylhydrazones as Potential FabH Inhibitors: Synthesis, Antimicrobial Evaluation and Molecular Docking.
    Fernandes TB, Segretti ND, Lourenço FR, Cândido TM, Baby AR, Barbosa EG, Parise-Filho R.
    Med Chem; 2021 Aug 01; 17(5):474-484. PubMed ID: 31763975
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
    Cheng K, Xue JY, Zhu HL.
    Bioorg Med Chem Lett; 2013 Jul 15; 23(14):4235-8. PubMed ID: 23731945
    [Abstract] [Full Text] [Related]

  • 19. New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors.
    Segretti ND, Serafim RA, Segretti MC, Miyata M, Coelho FR, Augusto O, Ferreira EI.
    Bioorg Med Chem Lett; 2016 Aug 15; 26(16):3988-93. PubMed ID: 27426865
    [Abstract] [Full Text] [Related]

  • 20. Identification of a new binding site in E. coli FabH using Molecular dynamics simulations: validation by computational alanine mutagenesis and docking studies.
    Ramamoorthy D, Turos E, Guida WC.
    J Chem Inf Model; 2013 May 24; 53(5):1138-56. PubMed ID: 23581389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.